Profound Medical closed its purchase of Royal Philips' Sonalleve MR-HIFU business, valued at $6 million. Philips will maintain its distribution of Profound's prostate-tissue ablation platform, Tulsa-Pro, and will deliver manufacturing, installation and other services to Profound for a limited period under the companies' expanded non-exclusive strategic sales relationship.
Profound completes $6M deal to buy Philips' Sonalleve MR-HIFU business
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.